Benefits of a patient-assisted medication adherence program for long-acting injectable risperidone on high-cost outcomes in schizophrenia

Autor:	Frédéric Rouillon, B. Astruc, Jessica J Jalbert, Michel Rossignol, Lamiae Grimaldi-Bensouda, Lucien Abenhaim, B. David, R. Bennoune, Franck Baylé, B. Avouac
Rok vydání:	2014
Předmět:	medicine.medical_specialty Risperidone Long acting business.industry Schizophrenia (object-oriented programming) Health Policy Public Health Environmental and Occupational Health Medicine Medication adherence business Psychiatry medicine.drug
Zdroj:	Value in Health. 17(3)
ISSN:	1098-3015
DOI:	10.1016/j.jval.2014.03.1231
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef5abf2991abf472ae4561af0f60c7c3 Zobrazit plný text záznamu Full Text from ScienceDirect